Indeed, previous studies have shown that isolated abnormal Aβ levels in CU older adults are less predictive of future cognitive decline than when combined with abnormal tau levels (i.e., preclinical AD29, 30) or with the presence of SCD.31, 32, 33, 34, 35. The gene discussed is MAPT; the disease is Schnyder corneal dystrophy.